333 related articles for article (PubMed ID: 20674321)
1. Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?
Puel A; Picard C; Cypowyj S; Lilic D; Abel L; Casanova JL
Curr Opin Immunol; 2010 Aug; 22(4):467-74. PubMed ID: 20674321
[TBL] [Abstract][Full Text] [Related]
2. Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.
Puel A; Cypowyj S; Maródi L; Abel L; Picard C; Casanova JL
Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):616-22. PubMed ID: 23026768
[TBL] [Abstract][Full Text] [Related]
3. IL-17 and infections.
Ling Y; Puel A
Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():34-40. PubMed ID: 25398490
[TBL] [Abstract][Full Text] [Related]
4. Immunity to infection in IL-17-deficient mice and humans.
Cypowyj S; Picard C; Maródi L; Casanova JL; Puel A
Eur J Immunol; 2012 Sep; 42(9):2246-54. PubMed ID: 22949323
[TBL] [Abstract][Full Text] [Related]
5. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.
Kisand K; Bøe Wolff AS; Podkrajsek KT; Tserel L; Link M; Kisand KV; Ersvaer E; Perheentupa J; Erichsen MM; Bratanic N; Meloni A; Cetani F; Perniola R; Ergun-Longmire B; Maclaren N; Krohn KJ; Pura M; Schalke B; Ströbel P; Leite MI; Battelino T; Husebye ES; Peterson P; Willcox N; Meager A
J Exp Med; 2010 Feb; 207(2):299-308. PubMed ID: 20123959
[TBL] [Abstract][Full Text] [Related]
6. Primary immunodeficiencies underlying fungal infections.
Lanternier F; Cypowyj S; Picard C; Bustamante J; Lortholary O; Casanova JL; Puel A
Curr Opin Pediatr; 2013 Dec; 25(6):736-47. PubMed ID: 24240293
[TBL] [Abstract][Full Text] [Related]
7. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.
Puel A; Cypowyj S; Bustamante J; Wright JF; Liu L; Lim HK; Migaud M; Israel L; Chrabieh M; Audry M; Gumbleton M; Toulon A; Bodemer C; El-Baghdadi J; Whitters M; Paradis T; Brooks J; Collins M; Wolfman NM; Al-Muhsen S; Galicchio M; Abel L; Picard C; Casanova JL
Science; 2011 Apr; 332(6025):65-8. PubMed ID: 21350122
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy and other primary immunodeficiency diseases help to resolve the nature of protective immunity against chronic mucocutaneous candidiasis.
Kisand K; Peterson P
Curr Opin Pediatr; 2013 Dec; 25(6):715-21. PubMed ID: 24240291
[TBL] [Abstract][Full Text] [Related]
9. Th2 and Th9 responses in patients with chronic mucocutaneous candidiasis and hyper-IgE syndrome.
Becker KL; Rösler B; Wang X; Lachmandas E; Kamsteeg M; Jacobs CW; Joosten LA; Netea MG; van de Veerdonk FL
Clin Exp Allergy; 2016 Dec; 46(12):1564-1574. PubMed ID: 27474157
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.
Sarkadi AK; Taskó S; Csorba G; Tóth B; Erdős M; Maródi L
J Clin Immunol; 2014 Feb; 34(2):181-93. PubMed ID: 24493573
[TBL] [Abstract][Full Text] [Related]
11. IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations.
Okada S; Markle JG; Deenick EK; Mele F; Averbuch D; Lagos M; Alzahrani M; Al-Muhsen S; Halwani R; Ma CS; Wong N; Soudais C; Henderson LA; Marzouqa H; Shamma J; Gonzalez M; Martinez-Barricarte R; Okada C; Avery DT; Latorre D; Deswarte C; Jabot-Hanin F; Torrado E; Fountain J; Belkadi A; Itan Y; Boisson B; Migaud M; Arlehamn CSL; Sette A; Breton S; McCluskey J; Rossjohn J; de Villartay JP; Moshous D; Hambleton S; Latour S; Arkwright PD; Picard C; Lantz O; Engelhard D; Kobayashi M; Abel L; Cooper AM; Notarangelo LD; Boisson-Dupuis S; Puel A; Sallusto F; Bustamante J; Tangye SG; Casanova JL
Science; 2015 Aug; 349(6248):606-613. PubMed ID: 26160376
[TBL] [Abstract][Full Text] [Related]
12. Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy.
Huppler AR; Bishu S; Gaffen SL
Arthritis Res Ther; 2012 Jul; 14(4):217. PubMed ID: 22838497
[TBL] [Abstract][Full Text] [Related]
13. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22.
Eyerich K; Foerster S; Rombold S; Seidl HP; Behrendt H; Hofmann H; Ring J; Traidl-Hoffmann C
J Invest Dermatol; 2008 Nov; 128(11):2640-2645. PubMed ID: 18615114
[TBL] [Abstract][Full Text] [Related]
14. The Evolving View of IL-17-Mediated Immunity in Defense Against Mucocutaneous Candidiasis in Humans.
Soltész B; Tóth B; Sarkadi AK; Erdős M; Maródi L
Int Rev Immunol; 2015; 34(4):348-63. PubMed ID: 26154078
[TBL] [Abstract][Full Text] [Related]
15. Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity.
Okada S; Puel A; Casanova JL; Kobayashi M
Clin Transl Immunology; 2016 Dec; 5(12):e114. PubMed ID: 28090315
[TBL] [Abstract][Full Text] [Related]
16. Chronic and Invasive Fungal Infections in a Family with CARD9 Deficiency.
Alves de Medeiros AK; Lodewick E; Bogaert DJ; Haerynck F; Van Daele S; Lambrecht B; Bosma S; Vanderdonckt L; Lortholary O; Migaud M; Casanova JL; Puel A; Lanternier F; Lambert J; Brochez L; Dullaers M
J Clin Immunol; 2016 Apr; 36(3):204-9. PubMed ID: 26961233
[TBL] [Abstract][Full Text] [Related]
17. The Th17/IL-17 Axis and Host Defense Against Fungal Infections.
Tangye SG; Puel A
J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1624-1634. PubMed ID: 37116791
[TBL] [Abstract][Full Text] [Related]
18. Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis.
Ling Y; Cypowyj S; Aytekin C; Galicchio M; Camcioglu Y; Nepesov S; Ikinciogullari A; Dogu F; Belkadi A; Levy R; Migaud M; Boisson B; Bolze A; Itan Y; Goudin N; Cottineau J; Picard C; Abel L; Bustamante J; Casanova JL; Puel A
J Exp Med; 2015 May; 212(5):619-31. PubMed ID: 25918342
[TBL] [Abstract][Full Text] [Related]
19. New host defense mechanisms against Candida species clarify the basis of clinical phenotypes.
Hanna S; Etzioni A
J Allergy Clin Immunol; 2011 Jun; 127(6):1433-7. PubMed ID: 21497889
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I.
Puel A; Döffinger R; Natividad A; Chrabieh M; Barcenas-Morales G; Picard C; Cobat A; Ouachée-Chardin M; Toulon A; Bustamante J; Al-Muhsen S; Al-Owain M; Arkwright PD; Costigan C; McConnell V; Cant AJ; Abinun M; Polak M; Bougnères PF; Kumararatne D; Marodi L; Nahum A; Roifman C; Blanche S; Fischer A; Bodemer C; Abel L; Lilic D; Casanova JL
J Exp Med; 2010 Feb; 207(2):291-7. PubMed ID: 20123958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
